추천 제품
분석
≥90% (HPLC)
형태
powder
색상
white to beige
solubility
DMSO: 2 mg/mL, clear
저장 온도
−20°C
SMILES string
[H][C@@]1([C@@]2(CCC1)[H])CN(C([C@@H](NC([C@@H](NC(C3=NC=CN=C3)=O)C4CCCCC4)=O)C(C)(C)C)=O)[C@@H]2C(N[C@H](C(C(NC5CC5)=O)=O)CCC)=O
생화학적/생리학적 작용
Telaprevir is a potent, selective and orally active hepatitis C virus (HCV) NS3.4A serine protease inhibitor. Telaprevir also inhibits chymotrypsin, chymase, elastase, and cathepsins F, K, L, S, and V in vitro
신호어
Warning
유해 및 위험 성명서
Hazard Classifications
Repr. 2
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
Journal of immunology (Baltimore, Md. : 1950), 200(3), 1124-1132 (2017-12-22)
The contribution of the host immune system to the efficacy of new anti-hepatitis C virus (HCV) drugs is unclear. We undertook a longitudinal prospective study of 33 individuals with chronic HCV treated with combination pegylated IFN-α, ribavirin, and telaprevir/boceprevir. We
Antimicrobial agents and chemotherapy, 50(3), 899-909 (2006-02-24)
VX-950 is a potent, selective, peptidomimetic inhibitor of the hepatitis C virus (HCV) NS3-4A serine protease, and it demonstrated excellent antiviral activity both in genotype 1b HCV replicon cells (50% inhibitory concentration [IC50] = 354 nM) and in human fetal
Hepatology research : the official journal of the Japan Society of Hepatology, 48(2), 184-192 (2017-05-13)
To assess the efficacy and safety of telaprevir (TVR) when used in combination with natural human interferon-β (IFN-β) and ribavirin (RBV) for genotype 1 patients with depression compared to IFN-β/RBV therapy in Japan. We also examined the efficacy of the
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.